Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Tayfur TOPTAS"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 18-19 (2024)
Objective: Mediastinal gray zone lymphoma (MGZL) is a rare B cell lymphoma originated from the thymic niche. An incostistency between morphological and immunohistochemical findings is the hallmark of the disease . Both 2022 WHO classification and Int
Externí odkaz:
https://doaj.org/article/67564ac71fed482392271a3760710dde
Autor:
Fatma Arikan, Pinar Ata, Senol Demir, Ozlem Yildirim, Özgür Mehtap, Atakan Erol, Bedrettin Orhan, Fahir Ozkalemkas, Meral Ulukoylu Menguc, Derya Demirtas, Ahmet Mert Yanik, Ozlem Candan, Tayfur Toptas, Ayse Tulin Tuglular
Publikováno v:
HemaSphere, Vol 7, p e87663b9 (2023)
Externí odkaz:
https://doaj.org/article/8375a465ec544096b6d06ddad0ef2dbf
Autor:
Özgür Mehtap, Tayfur Toptas, Mehmet Sinan Dal, Güner Hayri Özsan, Nigün Sayinalp, Güray Saydam, Mehmet Ali Uçar, Hakki Onur Kirgizlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedil Tanrikulu, Olga Meltem Akay, Emrah Kiliçaslan, Semra Paydas, Sinem Civriz, Mehmet Yilmaz, Volkan Karakuş, Fatma Geçgel, Tahir Darçin, Elçin Erdoğan, Erkin Çinar, Fatma Keklik Karadağ, Ünal Ataş, Vildan Gürsoy, Salih Sertaç Durusoy, Elif Birtaş Ateşoğlu, Anil Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Ahmet Burhan Ferhanoğlu
Publikováno v:
HemaSphere, Vol 7, p e566791c (2023)
Externí odkaz:
https://doaj.org/article/e9b3c75689fe4673b443fbabb3a75f21
Publikováno v:
HemaSphere, Vol 7, p e96979d7 (2023)
Externí odkaz:
https://doaj.org/article/518cf38df6054bde9121edd57f1db4e3
Autor:
Tayfur Toptas, Birkan Ilhan, Huseyin Bilgin, Elif Dincses, Osman Ozdogan, Isik Kaygusuz-Atagunduz, Zekaver Odabasi, Volkan Korten, Tulin Firatli-Tuglular
Publikováno v:
Case Reports in Infectious Diseases, Vol 2015 (2015)
Hepatobiliary tuberculosis is uncommon even in endemic countries. It is associated with a high mortality and is even diagnosed early in the disease course. Acute liver failure (ALF) caused by tuberculosis bacilli has been reported in only a few repor
Externí odkaz:
https://doaj.org/article/e72ec51bcdab4e7f94c704004ed335af
Autor:
Elif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, Muhit Ozcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Fergun Yilmaz, Derya Koyun, Nihan Alkis, Inci Alacacioglu, Mehmet Sonmez, Irfan Yavasoglu, Anil Tombak, Ozgur Mehtap, Fatih Kurnaz, Orhan Kemal Yuce, Volkan Karakus, Mehmet Turgut, Derya Deniz Kurekci, Mesut Ayer, Muzaffer Keklik, Deram Buyuktas, Murat Ozbalak, Burhan Ferhanoglu
Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and survival rates were recently reported in a pivotal phase II expansion trial conducted in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2497f4e81be510fd6626ab724fb52159
https://hdl.handle.net/11424/289907
https://hdl.handle.net/11424/289907
Publikováno v:
Cureus.
Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare genetic condition characterized by persistent hyperferritinemia (usually ferritin >1,000 ng/mL) without tissue iron overload, with or without early-onset slow-progressing bilateral nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aee407a41ac4abaa6c92e06fbca09e7
https://doi.org/10.7759/cureus.36253
https://doi.org/10.7759/cureus.36253
Autor:
Fatma Arikan, Tayfur Toptas, Isik Kaygusuz Atagunduz, Tarik Ercan, Ozen Oruc, Fergun Yilmaz, Tulin Tuglular
Publikováno v:
Blood research
Background In this retrospective cohort of patients with primary, post-polycythemia vera, or post-essential thrombocythemia myelofibrosis, 57 patients with MF who received ruxolitinib for MF-related symptoms or symptomatic splenomegaly were evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff37a1c33b918a2131cbdafca610224
http://europepmc.org/articles/PMC8721444
http://europepmc.org/articles/PMC8721444
Autor:
Tayfur Toptas, Tulin Firatli Tuglular, Serdar Ozkok, Aslihan Sezgin, Fatma Gecgel, Toluy Ozgumus, Osman Kara, Isik Kaygusuz Atagunduz
Publikováno v:
Indian J Hematol Blood Transfus
Immune thrombocytopenia (ITP) is a rare autoimmune disorder presenting with isolated thrombocytopenia. Splenectomy is still one of the treatment alternatives for these patients. Here we aim to analyze long term follow-up data of splenectomy in immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405597efca4a66b8b2df1ea1e792af91
https://doi.org/10.1007/s12288-021-01467-0
https://doi.org/10.1007/s12288-021-01467-0
Autor:
Elif Gülsüm Ümit, Ahmet Muzaffer Demir, Muhlis Cem Ar, Mesut Ayer, Meltem Aylı, Volkan Karakuş, Emin Kaya, Fahir Özkalemkaş, Nilgün Sayınalp, Mehmet Sönmez, Fahri Şahin, Selami Koçak Toprak, Tayfur Toptaş, İrfan Yavaşoğlu, Ümran Çalış
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 3, Pp 141-145 (2024)
Objective: Primary immune thrombocytopenia (ITP) is an acquired disorder of platelets with a complex and unclear mechanism of increased immune destruction or impaired production of platelets. While the management of ITP is evolving, there is still a
Externí odkaz:
https://doaj.org/article/054d63ab37a14969ae51686eef5b3e9e